Skip to content
Screener

Harrow HROW Interest Expense

Interest Expense at other companies

Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
-$840K+18.3%
Bausch + Lomb logo
Bausch + LombBLCO
$93M-27.3%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$2.78M-6.9%
Opko Health logo
Opko HealthOPK
$11.38M-83.8%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$402M+21.8%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$2.16M-3.8%

Other financials

Income statement

See full
Revenue$44.2M-7.6%
Gross profit$27.0M-16.3%
Operating income-$22.1M-96.6%
Net income-$27.6M-55.2%
EPS (diluted)-$0.74-48.0%

Balance sheet

See full
Cash & equivalents$94.6M+41.8%
Total debt$308.6M-32.9%
Total equity$28.7M-49.1%
Total assets$419.5M+15.2%

Cash flow

See full
Operating cash flow-$9.0M-146%
CapEx$194.0K+14.1%
Free cash flow-$9.2M-147%

Valuation

See full
Market cap$1.49B+22.8%
Enterprise value$1.7B+5.6%
P/S5.5×+0.2×

Profitability

See full
Gross margin74.1%-0.4pp
Operating margin7.3%+5.2pp
Net margin-19.8%+18.0pp
FCF margin5.7%+5.0pp

Returns & leverage

See full
Return on equity-50%+17.5pp
Debt / equity10.7×+2.6×
Current ratio2.5×+1.6×

Where this comes from

Reported directly by Harrow in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.

The source filing: Harrow’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 4:31 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001493152-26-022254
Line item2026 / For the Three Months Ended March 31,2025 / For the Three Months Ended March 31,
Research and development5,895,0003,026,000
Total operating expenses49,125,00043,539,000
Loss from operations(22,080,000)(11,232,000)
Interest expense, net(5,497,000)(6,548,000)
Loss before income taxes(27,577,000)(17,780,000)
Income tax expense(25,000)-
Net loss$(27,602,000)$(17,780,000)
Basic and diluted net loss per share of common stock$(0.74)$(0.50)

Item 1. Financial Statements (unaudited) Item

FAQ

What is Harrow's interest expense?
Harrow (HROW) reported interest expense of $5.5M in Q1 2026.
How has Harrow's interest expense changed year-over-year?
Harrow's interest expense decreased by 16.1% year-over-year, from $6.55M to $5.5M.
What is the long-term trend for Harrow's interest expense?
Over 4 years (2021 to 2025), Harrow's interest expense has grown at a 45.2% compound annual growth rate (CAGR), from $5.44M to $24.18M.
What does interest expense mean?
Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.

Ask your AI about Harrow's interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude